Anna Barker

Director, Transformative Healthcare Networks and Professor

  • 9987 Citations
  • 14 h-Index
1971 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Anna Barker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Inbred AKR Mouse Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Ethylamines Medicine & Life Sciences
Fluorenes Medicine & Life Sciences
Experimental Leukemias Medicine & Life Sciences
Interferon Inducers Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Vesicular stomatitis Indiana virus Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1971 2018

  • 9987 Citations
  • 14 h-Index
  • 33 Article
  • 2 Review article
12 Citations (Scopus)

Adaptive global innovative learning environment for glioblastoma: GBM AGILE

GBM AGILE Network, Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 737-743 7 p.

Research output: Contribution to journalReview article

Glioblastoma
Learning
Biomarkers
Therapeutics
Random Allocation
7 Citations (Scopus)

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes

Domenyuk, V., Gatalica, Z., Santhanam, R., Wei, X., Stark, A., Kennedy, P., Toussaint, B., Levenberg, S., Wang, J., Xiao, N., Greil, R., Rinnerthaler, G., Gampenrieder, S. P., Heimberger, A. B., Berry, D. A., Barker, A., Quackenbush, J., Marshall, J. L., Poste, G., Vacirca, J. L. & 9 othersVidal, G. A., Schwartzberg, L. S., Halbert, D. D., Voss, A., Magee, D., Miglarese, M. R., Famulok, M., Mayer, G. & Spetzler, D., Dec 1 2018, In : Nature Communications. 9, 1, 1219.

Research output: Contribution to journalArticle

breast
cancer
Breast Neoplasms
Ligands
ligands
43 Citations (Scopus)

Future cancer research priorities in the USA: a Lancet Oncology Commission

Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A., Bastani, R., Bhatia, S., Bluestone, J. A., Brawley, O., Butte, A. J., Coit, D. G., Davidson, N. E., Davis, M., DePinho, R. A., Diasio, R. B., Draetta, G., Frazier, A. L., Futreal, A. & 34 othersGambhir, S. S., Ganz, P. A., Garraway, L., Gerson, S., Gupta, S., Heath, J., Hoffman, R. I., Hudis, C., Hughes-Halbert, C., Ibrahim, R., Jadvar, H., Kavanagh, B., Kittles, R., Le, Q. T., Lippman, S. M., Mankoff, D., Mardis, E. R., Mayer, D. K., McMasters, K., Meropol, N. J., Mitchell, B., Naredi, P., Ornish, D., Pawlik, T. M., Peppercorn, J., Pomper, M. G., Raghavan, D., Ritchie, C., Schwarz, S. W., Sullivan, R., Wahl, R., Wolchok, J. D., Wong, S. L. & Yung, A., Nov 1 2017, In : The Lancet. Oncology. 18, 11, p. e653-e706

Research output: Contribution to journalReview article

Research
Neoplasms
Precision Medicine
Radiation Oncology
National Cancer Institute (U.S.)
4 Citations (Scopus)

The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis

Blakeley, J. O., Bakker, A., Barker, A., Clapp, W., Ferner, R., Fisher, M. J., Giovannini, M., Gutmann, D. H., Karajannis, M. A., Kissil, J. L., Legius, E., Lloyd, A. C., Packer, R. J., Ramesh, V., Riccardi, V. M., Stevenson, D. A., Ullrich, N. J., Upadhyaya, M. & Stemmer-Rachamimov, A., Jun 1 2017, In : American Journal of Medical Genetics, Part A. 173, 6, p. 1714-1721 8 p.

Research output: Contribution to journalArticle

Neurofibromatosis 2
Neurofibromatosis 1
Neurofibromatoses
Neoplasms
Drug Industry
12 Citations (Scopus)
Biomarkers
Research
Precision Medicine
Practice Guidelines
Private Sector

Projects 2012 2018